Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38 mitogen-activated protein kinases are a family of serine/threonine kinases that play a central role in cellular responses to stress and inflammation. They are part of the larger MAP kinase family, which transduces extracellular signals into various intracellular responses. Dysregulation or persistent activation of this pathway has been implicated in numerous diseases, including inflammatory disorders, cancer progression/metastasis, neurodegenerative diseases, cardiovascular disease and muscular dystrophies. Numerous small-molecule inhibitors targeting various isoforms have been developed for potential therapeutic use.
Inhibition of kinase activity by binding to the ATP binding site or other allosteric sites.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38 mitogen–activated protein kinase (p38 MAPK).